Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qishen Yiqi dropping pill versus Fufang Danshen dropping pill for stable angina due to coronary heart disease
ChiCTR-TTRCC-14004406Phase 4Completed
- Sponsor
- Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine
- Start
- May 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis and angina pectoris comparing Qishen Yiqi dropping pill + placebo with Fufang Danshen dropping pill + placebo (2 arms). Primary endpoint: Improvement of clinical symptoms. Started May 2014; status: completed.
02
Drugs
qishen yiqi dripping pillsCompound Danshen
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on ChiCTR-TTRCC-14004406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-14004406.